Provention Bio - 48 Year Dividend Yield History | PRVB

Historical dividend payout and yield for Provention Bio (PRVB) since 1971. The current TTM dividend payout for Provention Bio (PRVB) as of February 22, 2019 is $0.00. The current dividend yield for Provention Bio as of February 22, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.077B $0.000B
Provention Bio, Inc. is a biopharmaceutical company. It focuses on development of novel therapeutics and solutions to intercept and prevent immune-mediated disease. The company's product pipeline consists of PRV-031, PRV-6527, PRV-300, PRV-3279 and PRV-101 which are in clinical stage. Provention Bio, Inc. is based in NJ, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.316B 12.97
Gilead Sciences (GILD) United States $86.647B 10.87
Bio-Techne Corp (TECH) United States $7.316B 49.29